This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2002 Nov 26;167(11):1250-1.

Pharmaceutical cost containment with reference-based pricing: time for refinements

Sebastian Schneeweiss¹, Malcolm Maclure, Colin Dormuth, Jerry Avorn

Affiliations

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass 02115, USA. schneeweiss@post.harvard.edu

PMID: 12451080
PMCID: PMC134136

Pharmaceutical cost containment with reference-based pricing: time for refinements

Sebastian Schneeweiss et al. CMAJ. 2002.

. 2002 Nov 26;167(11):1250-1.

Authors

Sebastian Schneeweiss¹, Malcolm Maclure, Colin Dormuth, Jerry Avorn

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass 02115, USA. schneeweiss@post.harvard.edu

PMID: 12451080
PMCID: PMC134136

No abstract available

PubMed Disclaimer

Comment in

Reference-based refinements.
Graham J. Graham J. CMAJ. 2003 Apr 29;168(9):1114-5; author reply 1115. CMAJ. 2003. PMID: 12719311 Free PMC article. No abstract available.

Similar articles

Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
Schneeweiss S, Soumerai SB, Maclure M, Dormuth C, Walker AM, Glynn RJ. Schneeweiss S, et al. Clin Pharmacol Ther. 2003 Oct;74(4):388-400. doi: 10.1016/S0009-9236(03)00227-3. Clin Pharmacol Ther. 2003. PMID: 14534526
Evaluating reference-based pricing: initial findings and prospects.
Narine L, Senathirajah M, Smith T. Narine L, et al. CMAJ. 1999 Aug 10;161(3):286-8. CMAJ. 1999. PMID: 10463052 Free PMC article.
Reference-based pricing (RBP) of prescription drugs.
Holbrook A, O'Brien B, Grootendorst P. Holbrook A, et al. Can J Cardiol. 1997 Jul;13(7):689-90. Can J Cardiol. 1997. PMID: 9251582 No abstract available.
Reference-based pricing in British Columbia: implications for cardiologists--an analysis.
Boulet AP, Tessier G. Boulet AP, et al. Can J Cardiol. 1997 Jan;13(1):46-51. Can J Cardiol. 1997. PMID: 9039064 Review.
Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand.
Danzon PM, Ketcham JD. Danzon PM, et al. Front Health Policy Res. 2004;7:1-54. doi: 10.2202/1558-9544.1050. Front Health Policy Res. 2004. PMID: 15612334 Review.

See all similar articles

Cited by

First-line first? Trends in thiazide prescribing for hypertensive seniors.
Morgan S, Bassett KL, Wright JM, Yan L. Morgan S, et al. PLoS Med. 2005 Apr;2(4):e80. doi: 10.1371/journal.pmed.0020080. Epub 2005 Apr 26. PLoS Med. 2005. PMID: 15839739 Free PMC article.
Reference-based refinements.
Graham J. Graham J. CMAJ. 2003 Apr 29;168(9):1114-5; author reply 1115. CMAJ. 2003. PMID: 12719311 Free PMC article. No abstract available.
Potential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospital.
Lapointe-Shaw L, Fischer HD, Newman A, John-Baptiste A, Anderson GM, Rochon PA, Bell CM. Lapointe-Shaw L, et al. PLoS One. 2012;7(6):e39737. doi: 10.1371/journal.pone.0039737. Epub 2012 Jun 26. PLoS One. 2012. PMID: 22761882 Free PMC article.
Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.
Polinski JM, Maclure M, Marshall B, Cassels A, Agnew-Blais J, Patrick AR, Schneeweiss S. Polinski JM, et al. Can J Clin Pharmacol. 2008 Summer;15(2):e286-94. Epub 2008 Jul 19. Can J Clin Pharmacol. 2008. PMID: 18641423 Free PMC article.

References

1. Huskamp HA, Rosenthal MB, Frank RG, Newhouse JP. The Medicare prescription drug benefit: How will the game be played? Health Aff (Millwood) 2000;19(2):8-23. - PubMed
1. Morgan S. Statistics and drug utilization: Are prescribing rates really that high? CMAJ 2001;165(11):1507-8. - PMC - PubMed
1. Iglehart JK. Health policy 2001: Medicare and prescription drugs. N Engl J Med 2001; 344:1010-5. - PubMed
1. Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure: Is there anything to be learned? Pharmacoeconomics. In press. - PubMed
1. Dickson M, Poullier JP. Prescription reimbursement systems in selected European countries. In: Huttin C, Bosanquet N, editors. The prescription drug market: international perspectives and challenges for the future. Vol. 17. Advanced series in management. Amsterdam: Elsevier Science Publishers; 1995. p. 107-38.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources